CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 34,240 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 43,578 shares (grant or award)
- 4 Grant or award EVP Neuroscience R&D acquired 39,624 shares (grant or award)
- 4 Grant or award Director acquired 34,240 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 39,624 shares (grant or award)
- 4 Grant or award EVP Neuroscience Product Dev. acquired 39,624 shares (grant or award)
- 4 Grant or award Director acquired 43,578 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 39,624 shares (grant or award)
- 4 Grant or award CEO & President acquired 79,248 shares (grant or award)
- 4 Grant or award EVP Liver Cirrhosis R&D acquired 39,624 shares (grant or award)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- RW Other RW
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
Page 11 of 26 · 511 filings